Skip to content
Screener

Upstream Bio, Inc. UPB Operating Lease Liabilities (Total)

Operating Lease Liabilities (Total) at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$266.8M+13.8%
Aclaris Therapeutics logo
Aclaris TherapeuticsACRS
$1.85M-21.8%
Savara logo
SavaraSVRA
$1.09M
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$13.61K-99.9%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$242K-64.4%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$2.07M+36.3%

Other financials

Income statement

See full
Revenue$773.0K-17.5%
Operating income-$42.4M+4.5%
Net income-$39.7M+0.7%
EPS (diluted)-$0.73+1.4%

Balance sheet

See full
Cash & equivalents$79.4M+74.7%
Total debt$954.0K-38.9%
Total equity$271.0M-33.7%
Total assets$281.2M-33.1%

Cash flow

See full
Operating cash flow-$35.6M+9.2%
CapEx$54.0K-70.8%
Free cash flow-$30.7M-55.0%

Valuation

See full
Market cap$394.54M-54.7%
Enterprise value$316.1M-61.6%
P/S124.9×-195×

Profitability

See full
Operating margin-5,382.6%+1,393pp
Net margin-4,955.7%+2,041pp

Returns & leverage

See full
Return on equity-46%
Debt / equity0.0×
Current ratio28×-10.3×

Where this comes from

Reported directly by Upstream Bio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.

The source filing: Upstream Bio, Inc.’s 10-K, filed March 26, 2026.

Filed
Mar 26, 2026, 4:04 PM EDT
Fiscal year
FY2025
Accession
0001193125-26-126188
Year Ended December 31,Amount
2026759
2027644
Total lease payments1,403
Less: imputed interest(134)
Present value of lease liabilities1,269
Less: operating lease liabilities, current portion(720)
Operating lease liabilities, net of current portion$549

Item 16. Form 10-K Summary.

FAQ

What is Upstream Bio, Inc.'s operating lease liabilities (total)?
Upstream Bio, Inc. (UPB) reported operating lease liabilities (total) of $1.27M in Q4 2025.
What does operating lease liabilities (total) mean?
This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.

Ask your AI about Upstream Bio, Inc.'s operating lease liabilities (total).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude